Aug. 11 at 4:04 PM
$RDNT: RadNet is looking pretty rad to investors today. Shares of this diagnostic imaging company are surging following its Q2 report this morning. Adjusted EPS nearly doubled yr/yr to
$0.31, which was much better than expected. Revenue was also impressive, growing 8.4% yr/yr to
$498.2 mln, which was a good bit above analyst expectations. Adjusted EBITDA margin improved to 16.3% from 15.7% a year ago.
#RadNet #HealthCare #Tech #AI #earnings #guidance #stocks #Bonds #economy #investing #trading #stockmarket